Equasens (EQS) | Stock Overview & Key Data
Equasens | Mid-cap | Healthcare
Equasens | Mid-cap | Healthcare
Equasens Performance Comparison
Stock Range
Today's Range
Low: €49.65
High: €51.40
on August 8, 2025
52 Week Range
Low: €30.55
High: €56.70
on April 7, 2025
on October 4, 2024
All-Time High: €124.20 on January 18, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€756.1M
EPS
3.11
P/E Ratio (TTM)
16.17
Forward P/E
16.99
P/B Ratio
3.27
PEG Ratio
16.99
Div. Yield
2.53%
ROE
16.13%
Beta
0.870
Debt to Equity
25.65
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
26.51%
Profit Margin
16.72%
Returns and Earnings
Return on Assets (TTM)
7.04%
Return on Equity (TTM)
16.13%
EBITDA
€72.2M
Net Income (TTM)
€36.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€14.42
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Dividend Information
Last 12-Month Dividend
€1.25
Current Dividend Yield
2.53%
3-Year Average Dividend Yield
2.08%
3-Year Average Annual Dividend
€1.22
3-Year Total Dividends
€3.65
Ex-Dividend Date
July 2, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Equasens EQS | 756.07M Mid-cap | 3.71% | 1.62% | 19.62% | 35.40% | 12.03% | 8.52% | -38.81% | -39.32% |
| Cegedim S.A CGM | 147.32M Small-cap | -1.83% | -4.46% | -8.94% | -11.57% | -19.25% | -13.01% | -48.56% | -60.95% |
| Abl Diagnostics ABLD | 86.82M Small-cap | -11.76% | -15.89% | -18.18% | 17.19% | 82.93% | 66.67% | -93.13% | -0.66% |
| Smaio S.A ALSMA | 43.03M Small-cap | -3.77% | 34.21% | 89.36% | 143.63% | 208.47% | 83.89% | 94.16% | 42.46% |
| Intrasense S.A ALINS | 15.38M Small-cap | 3.57% | 0.00% | 0.00% | 11.54% | 16.00% | -3.33% | -30.95% | -62.34% |
| Ama Corp Plc ALAMA | 12.52M Small-cap | 0.00% | -4.17% | 21.05% | -17.86% | 35.29% | 43.75% | -67.14% | -96.52% |
Ownership & Short Interest
Insider Ownership
66.84%
Institutional Ownership
11.88%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
12K
Average 90-Day Volume
10K
Equasens Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Equasens would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EQS's 52-week high and low?
- In the last 52 weeks, Equasens reached a high of €56.70 (on October 4, 2024) and a low of €30.55 (on April 7, 2025).
- What is the market cap and P/E ratio for EQS?
- Curious about Equasens's size and valuation? Its market capitalization stands at 756.07M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.17, and the forward P/E (looking ahead) is 16.99.
- Does EQS pay dividends? If so, what's the yield?
- Yes, Equasens is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.53%, and the company has paid an average of €1.22 per share annually over the past 3 years.
- Who are Equasens's main competitors or similar companies to consider before investing?
When looking at Equasens, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Cegedim S.A
CGM147.32M Healthcare Health Information Services -13.01% -48.56% Abl Diagnostics
ABLD86.82M Healthcare Health Information Services 66.67% -93.13% Smaio S.A
ALSMA43.03M Healthcare Health Information Services 83.89% 94.16% Intrasense S.A
ALINS15.38M Healthcare Health Information Services -3.33% -30.95% Ama Corp Plc
ALAMA12.52M Healthcare Health Information Services 43.75% -67.14% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Equasens? (e.g., ROE, Debt/Equity)
- To get a sense of Equasens's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.13%, the Debt to Equity ratio from the most recent quarter is 25.65, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EQS?
- Looking at Equasens's growth, its revenue over the trailing twelve months (TTM) was €217M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of EQS stock is held by insiders and institutions?
- Wondering who owns Equasens stock? Company insiders (like executives and directors) hold about 66.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 11.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.